Travanti Pharma's Series B Round

Travanti Pharma raised a round of funding on July 17, 2006.

Transdermal delivery of drugs and cosmetic agents utilizing active-patch technology. The company was acquired by Teikoku.…

Articles about Travanti Pharma's Series B Round: